Decreased bone mineral density during GnRH analog therapy and polymorphism of estrogen receptor gene in precocious puberty

Endocr J. 1999 Mar:46 Suppl:S55-7. doi: 10.1507/endocrj.46.suppl_s55.

Authors

Y Nakayama¹, R Tadokoro, O Arisaka, A Tokita, Y Yamashiro

Affiliation

¹ Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan.

PMID: 12054121
DOI: 10.1507/endocrj.46.suppl_s55

No abstract available

MeSH terms

Bone Density / drug effects*
Buserelin / pharmacology*
Child
Child, Preschool
Female
Gonadotropin-Releasing Hormone / adverse effects*
Gonadotropin-Releasing Hormone / analogs & derivatives*
Gonadotropin-Releasing Hormone / therapeutic use
Humans
Leuprolide / pharmacology*
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Puberty, Precocious / drug therapy*
Puberty, Precocious / genetics
Puberty, Precocious / metabolism
Receptors, Estrogen / genetics*

Substances

Receptors, Estrogen
Gonadotropin-Releasing Hormone
LHRH, Ala(6)-Gly(10)-ethylamide-
Leuprolide
Buserelin